首页> 外文期刊>Theriogenology >Effects of FSH commercial preparation and follicular status on follicular growth and superovulatory response in spanish merino ewes
【24h】

Effects of FSH commercial preparation and follicular status on follicular growth and superovulatory response in spanish merino ewes

机译:FSH商业制剂和卵泡状态对西班牙美利奴母羊卵泡生长和超排卵反应的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Ovarian follicular development was characterized in 24 Spanish Merino ewes to study effects of the follicular status and the FSH commercial product used on follicular growth and subsequent superovulatory response. Estrus was synchronized using 40 mg fluorogestone acetate sponges. The superovulatory treatment consisted in 2 daily im injections of FSH from 48 h before to 12 h after sponge removal. Sheep were assigned randomly to 2 groups treated with 6 decreasing doses (4, 4, 3, 3, 2, 2 mg) of FSH-P~(TM) or with 6 doses of 1.25 mL of OVAGEN~(TM). Growth and regression of all follicles >=2 mm were observed by transrectal ultrasonography, and recorded daily from Day 6 before sponge insertion to the first FSH injection, and then twice daily until estrus was detected with vasectomized rams. Differences were detected in follicular development from the first FSH injection to detection of estrus (-48 to 36 h from sponge removal) between groups. Administration of FSH-P increased the appearance of new follicles with respect to OVAGEN (6.3 +-0.7 vs 4.8 +- 0.4; P < 0.05), and the mean number of medium (4 to 5 mm) follicles (8.9 +- 1.2 vs 6.6 +- 0.9; P < 0.05). However, the mean number of follicles that regressed in size after sponge removal (5.9 +- 0.4 vs 3.3 +- 0.4) and the number of preovulatory sized follicles that did not ovulate (60 vs 42.4%) were also higher in FSH-P treated ewes (P < 0.05). So, finally, there were no differences in ovulation rate, as determined by laparoscopy on Day 7 after sponge removal, between ewes treated with FSH-P or OVAGEN (6.3 +- 1.9 vs 7.0 +- 1.7 CL). In all the ewes, the ovulatory response was related (P < 0.05) both to the number of small follicles (2 to 3 mm in diameter) present in the ovaries at the start of treatment with exogenous FSH and to the number of follicles that reached >=4 mm in size at estrus, despite differences in the pattern of follicular development when using different commercial products.
机译:在西班牙的24头美利奴羊母羊中,以卵巢卵泡发育为特征,以研究卵泡状态和FSH商业产品对卵泡生长和随后的超排卵反应的影响。使用40 mg氟代氟乙酸乙酸酯海绵同步发情。超排卵治疗包括从海绵去除前48小时到去除海绵后12小时每天2次FSH的即时注射。将绵羊随机分为两组,分别用6种递减剂量(4、4、3、3、2、2 mg)的FSH-P〜TM或6种剂量的1.25 mL OVAGEN〜TM处理。通过直肠超声检查观察所有> 2 mm卵泡的生长和消退,并从海绵插入前第6天到第一次FSH注射每天记录一次,然后每天记录两次,直到用输精管切除的公羊检测到发情。从第一次FSH注射到发情期检测(从海绵去除到-48至36小时)之间的卵泡发育之间存在差异。相对于OVAGEN,FSH-P的使用增加了新卵泡的出现(6.3 + -0.7 vs 4.8 +-0.4; P <0.05),以及中等卵泡(4至5 mm)的平均数(8.9 +-1.2vs。 6.6±0.9; P <0.05)。然而,FSH-P治疗后,去除海绵后大小消退的平均卵泡数量(5.9 +-0.4 vs 3.3 +-0.4)和未排卵的排卵前大小卵泡数量(60 vs 42.4%)也更高。母羊(P <0.05)。因此,最后,用FSH-P或OVAGEN处理的母羊,在去除海绵后第7天通过腹腔镜检查确定的排卵率没有差异(6.3±-1.9 vs 7.0±-1.7 CL)。在所有母羊中,排卵反应均与外源性FSH治疗开始时卵巢中存在的小卵泡数量(直径2至3 mm)有关(P <0.05)。尽管使用不同的商业产品时卵泡发育的模式有所不同,但发情期的大小仍大于等于4毫米。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号